Scap is required for sterol synthesis and crypt growth in intestinal mucosa

Matthew R. McFarlane, Mary Jo Cantoria, Albert G. Linden, Brandon A. January, Guosheng Liang, Luke J. Engelking

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

SREBP cleavage-activating protein (Scap) is an endoplasmic reticulum membrane protein required for cleavage and activation of sterol regulatory element-binding proteins (SREBPs), which activate the transcription of genes in sterol and fatty acid biosynthesis. Liver-specific loss of Scap is well tolerated; hepatic synthesis of sterols and fatty acids is reduced, but mice are otherwise healthy. To determine whether Scap loss is tolerated in the intestine, we generated a mouse model ( Vil-Scap <sup>-</sup> ) in which tamoxifen-inducible Cre-ER<sup>T2</sup> , a fusion protein of Cre recombinase with a mutated ligand binding domain of the human estrogen receptor, ablates Scap in intestinal mucosa. After 4 days of tamoxifen, Vil-Scap <sup>-</sup> mice succumb with a severe enteropathy and nearcomplete collapse of intestinal mucosa. Organoids grown ex vivo from intestinal crypts of Vil-Scap <sup>-</sup> mice are readily killed when Scap is deleted by 4-hydroxytamoxifen. Death is prevented when culture medium is supplemented with cholesterol and oleate. These data show that, unlike the liver, the intestine requires Scap to sustain tissue integrity by maintaining the high levels of lipid synthesis necessary for proliferation of intestinal crypts.

Original languageEnglish (US)
Pages (from-to)1560-1571
Number of pages12
JournalJournal of Lipid Research
Volume56
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Sterols
Intestinal Mucosa
Growth
Sterol Regulatory Element Binding Proteins
Tamoxifen
Liver
Intestines
Fatty Acids
Organoids
SREBP cleavage-activating protein
Mucous Membrane
Biosynthesis
Transcription
Endoplasmic Reticulum
Estrogen Receptors
Culture Media
Membrane Proteins
Proteins
Fusion reactions
Genes

Keywords

  • Cholesterol/biosynthesis
  • Fatty acid/synthesis
  • Gene expression
  • Niemann-Pick C1-like 1 protein
  • Nuclear receptors/sterol regulatory element-binding protein
  • Organoid, intestine
  • SREBP cleavage-activating protein

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Endocrinology

Cite this

Scap is required for sterol synthesis and crypt growth in intestinal mucosa. / McFarlane, Matthew R.; Cantoria, Mary Jo; Linden, Albert G.; January, Brandon A.; Liang, Guosheng; Engelking, Luke J.

In: Journal of Lipid Research, Vol. 56, No. 8, 01.08.2015, p. 1560-1571.

Research output: Contribution to journalArticle

McFarlane, Matthew R. ; Cantoria, Mary Jo ; Linden, Albert G. ; January, Brandon A. ; Liang, Guosheng ; Engelking, Luke J. / Scap is required for sterol synthesis and crypt growth in intestinal mucosa. In: Journal of Lipid Research. 2015 ; Vol. 56, No. 8. pp. 1560-1571.
@article{b23751ac5b5f466d9c3bb869573cd55e,
title = "Scap is required for sterol synthesis and crypt growth in intestinal mucosa",
abstract = "SREBP cleavage-activating protein (Scap) is an endoplasmic reticulum membrane protein required for cleavage and activation of sterol regulatory element-binding proteins (SREBPs), which activate the transcription of genes in sterol and fatty acid biosynthesis. Liver-specific loss of Scap is well tolerated; hepatic synthesis of sterols and fatty acids is reduced, but mice are otherwise healthy. To determine whether Scap loss is tolerated in the intestine, we generated a mouse model ( Vil-Scap - ) in which tamoxifen-inducible Cre-ERT2 , a fusion protein of Cre recombinase with a mutated ligand binding domain of the human estrogen receptor, ablates Scap in intestinal mucosa. After 4 days of tamoxifen, Vil-Scap - mice succumb with a severe enteropathy and nearcomplete collapse of intestinal mucosa. Organoids grown ex vivo from intestinal crypts of Vil-Scap - mice are readily killed when Scap is deleted by 4-hydroxytamoxifen. Death is prevented when culture medium is supplemented with cholesterol and oleate. These data show that, unlike the liver, the intestine requires Scap to sustain tissue integrity by maintaining the high levels of lipid synthesis necessary for proliferation of intestinal crypts.",
keywords = "Cholesterol/biosynthesis, Fatty acid/synthesis, Gene expression, Niemann-Pick C1-like 1 protein, Nuclear receptors/sterol regulatory element-binding protein, Organoid, intestine, SREBP cleavage-activating protein",
author = "McFarlane, {Matthew R.} and Cantoria, {Mary Jo} and Linden, {Albert G.} and January, {Brandon A.} and Guosheng Liang and Engelking, {Luke J.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1194/jlr.M059709",
language = "English (US)",
volume = "56",
pages = "1560--1571",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "8",

}

TY - JOUR

T1 - Scap is required for sterol synthesis and crypt growth in intestinal mucosa

AU - McFarlane, Matthew R.

AU - Cantoria, Mary Jo

AU - Linden, Albert G.

AU - January, Brandon A.

AU - Liang, Guosheng

AU - Engelking, Luke J.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - SREBP cleavage-activating protein (Scap) is an endoplasmic reticulum membrane protein required for cleavage and activation of sterol regulatory element-binding proteins (SREBPs), which activate the transcription of genes in sterol and fatty acid biosynthesis. Liver-specific loss of Scap is well tolerated; hepatic synthesis of sterols and fatty acids is reduced, but mice are otherwise healthy. To determine whether Scap loss is tolerated in the intestine, we generated a mouse model ( Vil-Scap - ) in which tamoxifen-inducible Cre-ERT2 , a fusion protein of Cre recombinase with a mutated ligand binding domain of the human estrogen receptor, ablates Scap in intestinal mucosa. After 4 days of tamoxifen, Vil-Scap - mice succumb with a severe enteropathy and nearcomplete collapse of intestinal mucosa. Organoids grown ex vivo from intestinal crypts of Vil-Scap - mice are readily killed when Scap is deleted by 4-hydroxytamoxifen. Death is prevented when culture medium is supplemented with cholesterol and oleate. These data show that, unlike the liver, the intestine requires Scap to sustain tissue integrity by maintaining the high levels of lipid synthesis necessary for proliferation of intestinal crypts.

AB - SREBP cleavage-activating protein (Scap) is an endoplasmic reticulum membrane protein required for cleavage and activation of sterol regulatory element-binding proteins (SREBPs), which activate the transcription of genes in sterol and fatty acid biosynthesis. Liver-specific loss of Scap is well tolerated; hepatic synthesis of sterols and fatty acids is reduced, but mice are otherwise healthy. To determine whether Scap loss is tolerated in the intestine, we generated a mouse model ( Vil-Scap - ) in which tamoxifen-inducible Cre-ERT2 , a fusion protein of Cre recombinase with a mutated ligand binding domain of the human estrogen receptor, ablates Scap in intestinal mucosa. After 4 days of tamoxifen, Vil-Scap - mice succumb with a severe enteropathy and nearcomplete collapse of intestinal mucosa. Organoids grown ex vivo from intestinal crypts of Vil-Scap - mice are readily killed when Scap is deleted by 4-hydroxytamoxifen. Death is prevented when culture medium is supplemented with cholesterol and oleate. These data show that, unlike the liver, the intestine requires Scap to sustain tissue integrity by maintaining the high levels of lipid synthesis necessary for proliferation of intestinal crypts.

KW - Cholesterol/biosynthesis

KW - Fatty acid/synthesis

KW - Gene expression

KW - Niemann-Pick C1-like 1 protein

KW - Nuclear receptors/sterol regulatory element-binding protein

KW - Organoid, intestine

KW - SREBP cleavage-activating protein

UR - http://www.scopus.com/inward/record.url?scp=84940490178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940490178&partnerID=8YFLogxK

U2 - 10.1194/jlr.M059709

DO - 10.1194/jlr.M059709

M3 - Article

VL - 56

SP - 1560

EP - 1571

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 8

ER -